Skip to content
GenoLensGenoLens

PDE6D

Chr 2q37.1

phosphodiesterase 6D

Aliases:
JBTS22
MANE:
ENST00000287600.9

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Moderate Evidence (Amber)

  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Limb disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Structural eye disease

    BIALLELIC, autosomal or pseudoautosomal
  • Neurological ciliopathies

    BIALLELIC, autosomal or pseudoautosomal
  • Ophthalmological ciliopathies

    BIALLELIC, autosomal or pseudoautosomal
  • Rare multisystem ciliopathy disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Renal ciliopathies

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • Joubert syndrome with orofaciodigital defect

    0.67
  • coronary artery disorder

    0.54
  • stroke disorder

    0.53
  • cardiovascular disorder

    0.43
  • intermittent vascular claudication

    0.43
  • cancer

    0.38
  • Joubert syndrome

    0.38
  • Hypertension

    0.37
  • orofaciodigital syndrome type 6

    0.37
  • Recurrent thrombophlebitis

    0.37

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta

Promotes the release of prenylated target proteins from cellular membranes (PubMed:9712853). Modulates the activity of prenylated or palmitoylated Ras family members by regulating their subcellular location (PubMed:22002721, PubMed:23698361). Required for normal ciliary targeting of farnesylated target proteins, such as INPP5E (PubMed:24166846). Required for RAB28 localization to the cone cell outer segments in the retina (By similarity). Modulates the subcellular location of target proteins by acting as a GTP specific dissociation inhibitor (GDI) (By similarity). Increases the affinity of ARL3 for GTP by several orders of magnitude. Stabilizes ARL3-GTP by decreasing the nucleotide dissociation rate (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.